Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab
Clinical trial NCT03992729 · RECRUITING
Trial details
- NCT number
- NCT03992729
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-29
- Primary completion
- 2028-07-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.